Pharmacological characterization of protein phosphatase activities in preparations from failing human hearts

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 1, 1999, Pages 188-193

  Neumann, Joachim ^a   Maas, Renke ^b   Bokník, Peter ^a   Jones, Larry R ^c   Zimmermann, Norbert ^b   Scholz, Hasso ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BETA ADRENERGIC RECEPTOR; CANTHARIDIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; OKADAIC ACID; PHOSPHOLAMBAN; PHOSPHOPROTEIN; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A;

ARTICLE; DEPHOSPHORYLATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; HEART CONTRACTION; HEART LEFT VENTRICLE; HEART MUSCLE; HUMAN; HUMAN TISSUE; MEMBRANE VESICLE; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM;

EID: 0032893050     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ahmad Z, Green FJ, Subuhi HS and Watanabe AM (1989) Autonomic regulation of type 1 protein phosphatase in cardiac muscle. J Biol Chem 264:5859-3863.
2. Bokník P, Fockenbrock M, Kirchhefer U, Knapp J, Linck B, Luess H, Müller FU, Müller T, Neumann J, Vahlensieck U and Schmitz W (1997) Protein phosphatases are functionally increased in a model of heart hypertrophy. Circulation 96(Suppl): 1-744.
3. Chen Z, Jones LR, O'Brian JJ, Moorman JR and Cala SE (1998) Structural domains in phospholemman. A possible role for the carboxyl terminus in channel inactivation. Circ Res 82:367-374.
4. Cohen P (1989) The structure and regulation of protein phosphatases. Annu Rev Biochem 58:453-508.
5. Depaoli-Roach AA, Park IK, Cerovsky V, Csortos S, Durbin SD, Kuntz MJ, Sitikov A, Tang PM, Verin A and Zolnierowicz S (1994) Serine/threonine protein phosphatases in the control of cell function. Adv Enzyme Regul 34:199-244.
6. Erdödi F, Csortos S, Bot G and Gergely P (1985) Separation of rabbit liver latent and spontaneously active phosphorylase phosphatases by chromatography on heparin Sepharose. Biochem Biophys Res Commun 128:705-712.
7. Gupta RC, Taimura M, Mishima T, Lesch M and Sabbah HN (1997) Protein phosphatase activity is increased and state of phosphorylation of phospholamban is decreased in myocardium of dogs with chronic heart failure. Circulation 96 (Suppl 1)-361.
8. Herzig S, Meier A, Pfeiffer M and Neumann J (1995) Stimulation of protein phosphatases as a mechanism of the muscarinic receptor-mediated inhibition of cardiac L-type calcium channels. Pflügers Arch 429:531-538.
9. Hescheler J, Mieskes G, Rüegg JC, Takai A and Trautwein W (1988) Effects of a protein phosphatase inhibitor, okadaic acid, on membrane currents of isolated guinea-pig cardiac myocytes. Pflügers Arch 412:248-252.
10. Huang B, Qin D, Boutjir M and Gidh-Jain M (1997) Diminished basal phosphorylation level of phospholamban in left ventricular myocytes from rats with left coronary infarction. Role of β-adrenergic pathway. Gi, phosphodiesterase and phosphatase. Circulation 96 (Suppl 1): I-19.
11. Jones LR, Besch HR, Fleming JW, McConnaughey MM and Watanabe AM (1979) Separation of vesicles of cardiac sarcolemma from vesicles of cardiac sarcoplasmic reticulum. J Biol Chem 254:530-539.
12. Klein-Wiele O, Bokník P, Gombosova I, Knapp J, Lüss H, Müller FU, Müller TM, Vahlensieck U, Schmitz W, Zimmermann N and Neumann J (1998) Expression of protein phosphatase isoforms in the human heart. Naunyn-Schmiedebergs Arch Pharmacol 357 (Suppl 1):R108.
13. 3H]endothall thioanhydride binding site. Inhibitor specificity of cantharidin and ATP analogues. Biochem Pharmacol, 46:1435-1443.
14. Linck B, Bokník P, Müller FU, Neumann J, Schmitz W and Vahlensieck U (1996a) Effects of cantharidin on force of contraction and phosphatase activity in nonfailing and failing human hearts. Br J Pharmacol 119:545-550.
15. 2+-ATPase in failing and nonfailing human hearts. Cardiovasc Res 31:625-632.
16. 2+-ATPase activity in guinea pig ventricles. J Biol Chem 258:464-471.
17. Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, Doetschman T and Kranias, EG (1994) Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation. Circ Res 75:401-409.
18. MacDougall LK, Jones LR and Cohen P (1991) Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban. Eur J Biochem 196:725-734.
19. Moorman JR, Palmer CJ, John JE III, Durieux ME and Jones LR (1992) Phospholemman expression induces a hyperpolarization-activated chloride current in xenopous oocytes. J Biol Chem 267:14551-14554.
20. Moorman JR, Ackerman SJ, Kowdley GC, Griffin MP, Mounsey JP, Chen Z, Cala, SE, O'Brian JJ, Szabo G and Jones LR (1995) Unitary anion currents through phospholemman channel molecules. Nature (London) 377:737-740.
21. Neumann J, Gupta RC, Schmitz W, Scholz H, Nairn AC and Watanabe AM (1991) Evidence for isoproterenol-induced phosphorylation of phosphatase inhibitor-1 in the intact heart. Circ Res 69:1450-1457.
22. Neumann J, Bokník P, Herzig S, Schmitz W, Scholz H, Gupta RC and Watanabe AM (1993) Evidence for physiological functions of protein phosphatases in the heart. Evaluation with okadaic acid. Am J Physiol 265:H257-H266.
23. Neumann J, Bokník P, Herzig S, Schmitz W, Scholz H, Wiechen K and Zimmermann N (1994) Biochemical and electrophysiological mechanisms of the positive inotropic effect of calyculin A, a protein phosphatase inhibitor. J Pharmacol Exp Ther 271:535-541.
24. Neumann J, Eschenhagen T, Jones LR, Linck B, Schmitz W, Scholz, H and Zimmermann N (1997) Increased expression of cardiac phosphatases in patients with end-stage heart failure. J Mol Cell Cardiol 29:265-272.
25. Neumann J, Herzig S, Bokník P, Apel M, Kaspareit G, Schmitz W, Scholz H, Tepel M and Zimmermann N (1995) Biochemical and electrophysiological mechanisms of the positive inotropic effect of cantharidin, a phosphatase inhibitor. J Pharmacol Exp Ther 274:530-539.
26. Palmer CJ, Scott BT and Jones LR (1991) Purification and complete sequence determination of the major plasma membrane substrate for cAMP-dependent protein kinase and protein kinase C in myocardium. J Biol Chem 266:11126-11130.
27. Presti CF, Jones LR and Lindemann JP (1985a) Isoproterenol-induced phosphorylation of a 15-kilodalton sarcolemmal protein in intact myocardium. J Biol Chem 260:3860-3867.
28. Presti CF, Scott BT and Jones LR (1985b) Identification of an endogenous protein kinase C activity and its intrinsic 15-kilodalton substrate in purified canine cardiac sarcolemmal vesicles. J Biol Chem 260:13879-13889.
29. 2+-ATPase. J Biol Chem 270:9390-9397.
30. Simmerman HKB and Jones LR (1998) Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol Rev, 78:921-947.
31. Zimmermann N, Bokník P, Gams E, Gsell S, Jones LR, Maas R, Neumann J and Scholz H (1996) Mechanism of the contractile effects of 2,3-butanedione-monoxime in the mammalian heart. Naunyn-Schmiedebergs Arch Pharmacol 354:431-436.